Hey, explain me about the concept of fibrinolysis, you know. It is the final step where the clot is dissolved when the vessel got healed, right? So, this concept, explain me and what all are the testables through this concept in the USMLE Step 1. I want a topper-like notes, like useful for step 1.

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Finding Sources
I now have all the high-yield information needed from multiple authoritative sources. Let me compile the comprehensive USMLE Step 1 notes on fibrinolysis.

Fibrinolysis — USMLE Step 1 High-Yield Notes


The Big Picture

Fibrinolysis is the enzymatic dissolution of a fibrin clot after tissue repair. It is the counter-regulatory system to coagulation — just as thrombin is the master enzyme of coagulation, plasmin is the master enzyme of fibrinolysis. The two systems are activated in parallel during vascular injury, keeping each other in balance.
Your correction is partially right — fibrinolysis is activated during clot formation (not only after healing), to limit clot growth from the start, and then continues to dissolve the clot as the wound heals.

Core Pathway (The One Diagram You Must Know)

Fibrinolytic System — Activators and Inhibitors
Katzung's Basic and Clinical Pharmacology, 16e — The fibrinolytic system with pharmacologic modulators

Step-by-Step Mechanism

1. Plasminogen → Plasmin (The Key Conversion)

ComponentRole
PlasminogenInactive zymogen (precursor), circulates in blood
tPA (tissue plasminogen activator)Primary physiologic activator; released by endothelial cells
uPA (urokinase-type PA)Second activator; mainly drives extravascular fibrinolysis (inflammatory contexts)
PlasminActive serine protease; digests fibrin
  • tPA cleaves the Arg560–Val561 bond of plasminogen → generates active two-chain plasmin
  • Endothelial cells synthesize and release both tPA and uPA
  • tPA predominates under most physiologic conditions
  • The catalytic efficiency of tPA activation of plasminogen increases >300-fold in the presence of fibrin — this is why plasmin is generated on the clot surface, not diffusely in blood
— Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic and Clinical Pharmacology 16e

2. Why Is Fibrinolysis "Fibrin-Specific"? (Kringle Domains — HIGH YIELD)

  • Plasminogen and plasmin both have kringle domains — loop-like structures near their amino termini that bind to exposed lysine residues on fibrin
  • This anchors both plasminogen and tPA onto the clot surface → forms a ternary complex (fibrin + plasminogen + tPA) → massively accelerates plasmin generation locally
  • As plasmin begins degrading fibrin, it exposes new carboxy-terminal lysine residues → even more plasminogen and tPA binding → positive feedback loop of clot dissolution
  • Plasmin bound to fibrin is protected from circulating α₂-antiplasmin (its inhibitor) because the kringle domains are occupied
  • Result: plasmin acts only on the clot, not on circulating fibrinogen — "fibrin-specific"
⚠️ This specificity is lost at pharmacologic doses of tPA (alteplase) — too much plasmin overwhelms the inhibitory controls → systemic lytic state → bleeding risk
— Goodman & Gilman's; Harrison's Internal Medicine 22e

3. What Does Plasmin Actually Degrade?

SubstrateProductClinical Significance
Cross-linked fibrin (clot)D-dimer + fibrin degradation products (FDPs)D-dimer is diagnostic for DVT/PE, DIC
Fibrinogen (in systemic lysis)Fibrinogen degradation products (FDPs)Seen in DIC, thrombolytic overdose
Coagulation factors (at high doses)Degraded V, VIIIBleeding risk with thrombolytics
  • D-dimer is produced only when plasmin acts on cross-linked fibrin (Factor XIIIa-stabilized clot) — not from fibrinogen alone. This is its diagnostic value.
— Harrison's Internal Medicine 22e

Regulatory Inhibitors (The Brakes on the System)

InhibitorWhat It InhibitsNotes
PAI-1 (plasminogen activator inhibitor-1)tPA and uPAMajor inhibitor of plasminogen activators; synthesized by endothelial cells; rapidly clears tPA from blood
PAI-2tPA and uPA (lesser extent)Prominent in pregnancy
α₂-antiplasmin (α₂-plasmin inhibitor)PlasminMajor inhibitor of free plasmin; binds kringle domain 1 then blocks active site; overwhelmed by therapeutic tPA doses
TAFI (Thrombin-Activatable Fibrinolysis Inhibitor)Removes C-terminal lysines from fibrinLimits plasminogen/tPA binding; thrombin + thrombomodulin activates it
Factor XIIIaIndirectly (cross-links α₂-antiplasmin to fibrin)Prevents premature clot lysis
  • PAI-1 is the key reason tPA exerts little effect on circulating plasminogen in the absence of fibrin — tPA is rapidly neutralized before it can act systemically
  • α₂-antiplasmin is the main circulating safety net that mops up any plasmin that escapes the clot
— Goodman & Gilman's; Katzung 16e; Harrison's 22e

Pharmacology (Thrombolytics/Fibrinolytics) — HIGH YIELD

Drugs That ACTIVATE Fibrinolysis

DrugMechanismFibrin-Specific?Notes
Alteplase (tPA, rt-PA)Recombinant tPA → activates plasminogenYes (at physiologic doses)Drug of choice for ischemic stroke (within 4.5 hrs), STEMI if no PCI available
Reteplase (rPA)Recombinant tPA variantYesDouble bolus IV; used in STEMI
Tenecteplase (TNK-tPA)Engineered tPA variantYesSingle weight-based bolus; longer half-life; used in STEMI
StreptokinaseBacterial protein; binds plasminogen → forms an activator complexNo (non-fibrin-specific)Systemic lytic state; antigenic (↑ antibodies, allergic reactions); cannot re-use
Urokinase (uPA)Directly converts plasminogen → plasminNoUsed for catheter-directed thrombolysis
AnistreplaseStreptokinase + plasminogen complexNoOlder agent

Drug That INHIBITS Fibrinolysis

DrugMechanismUse
Aminocaproic acid (ε-aminocaproic acid)Lysine analogue → blocks kringle domains → prevents plasminogen/tPA binding to fibrinHemostasis after surgery, hemophilia bleeds, post-tonsillectomy bleeding
Tranexamic acid (TXA)Same mechanism as aminocaproic acid (lysine analogue)Trauma, surgical bleeding, heavy menstrual bleeding
Mnemonic: Aminocaproic acid = Anti-fibrinolytic — it occupies the lysine-binding sites so plasminogen cannot attach to fibrin.
— Katzung 16e; Lippincott Pharmacology; Goodman & Gilman's

Contraindications to Thrombolytics (Step 1 Favorite)

Absolute contraindications:
  • Prior intracranial hemorrhage (any time)
  • Ischemic stroke within 3 months (except acute stroke being treated, <4.5 hrs)
  • Suspected aortic dissection
  • Active internal bleeding (not menses)
  • Significant closed-head trauma/facial trauma within 3 months
  • SBP >180 or DBP >110 at presentation (severe uncontrolled hypertension)

Clinical Scenarios and Lab Findings

D-Dimer

  • Elevated D-dimer = evidence of fibrin clot formation AND lysis → used to rule OUT DVT/PE (high sensitivity, low specificity)
  • D-dimer is elevated in: DVT/PE, DIC, post-surgery, pregnancy, malignancy, infection
  • D-dimer is NOT elevated with just thrombocytopenia or with fibrinogen degradation (needs cross-linked fibrin)

DIC (Disseminated Intravascular Coagulation)

  • Pathologic activation of BOTH coagulation AND fibrinolysis simultaneously
  • Labs: ↑ PT, ↑ aPTT, ↑ D-dimer, ↑ FDPs, ↓ fibrinogen, ↓ platelets
  • Causes: sepsis, trauma, obstetric emergencies (abruptio placentae, amniotic fluid embolism), malignancy
  • Treat the underlying cause — DIC is often fatal if the underlying process cannot be controlled

Bleeding Complication of Thrombolytics

  • At pharmacologic doses, plasmin degrades Factors V and VIII in addition to fibrin → impairs thrombin generation → bleeding
  • Also dissolves fibrin in hemostatic plugs (normal wound seals) → more bleeding risk
  • Hemorrhage is the major adverse effect of all fibrinolytic drugs

USMLE Step 1 High-Yield Testable Points Summary

ConceptTestable Fact
Plasminogen activatortPA (physiologic); released by endothelial cells
Kringle domainsBind lysine on fibrin → clot specificity → protected from α₂-antiplasmin
Major inhibitor of plasminα₂-antiplasmin
Major inhibitor of tPAPAI-1
D-dimerProduct of cross-linked fibrin degradation; rules out DVT/PE
FDPs without D-dimerFrom fibrinogen degradation only (not cross-linked fibrin)
DIC labs↑ PT, ↑ aPTT, ↑ D-dimer, ↓ fibrinogen, ↓ platelets, schistocytes on smear
StreptokinaseAntigenic, non-fibrin-specific, cannot re-administer
Aminocaproic acid / TXALysine analogues → antifibrinolytic
Alteplase contraindicationsHemorrhagic stroke ever; ischemic stroke <3 months; aortic dissection
Fibrin specificity at high tPA dosesLOST → systemic lytic state → bleeding
Positive feedback in lysisPartial fibrin degradation exposes more lysine residues → more plasmin binding
TAFIThrombin-activatable fibrinolysis inhibitor; removes lysines → slows lysis
Factor XIIIa roleCross-links fibrin AND cross-links α₂-antiplasmin to fibrin → protects clot from early lysis

Memory Map

VESSEL INJURY
    ↓
Coagulation cascade → Thrombin → Fibrin clot (Factor XIIIa cross-links it)
    ↓ (simultaneously)
Endothelial cells release tPA
    ↓
tPA + Plasminogen bind to FIBRIN (via kringle-lysine interaction)
    → Ternary complex → Plasmin (locally generated, fibrin-specific)
    ↓
Plasmin degrades cross-linked fibrin → D-DIMER + FDPs
    ↓
Clot dissolves; vessel patent again

INHIBITORS:
  PAI-1 → blocks tPA/uPA
  α₂-antiplasmin → blocks free plasmin
  TAFI → removes lysines from fibrin (limits plasmin binding)
  Aminocaproic acid / TXA → occupy lysine binding sites (drugs)

Sources: Katzung's Basic and Clinical Pharmacology 16e | Goodman & Gilman's Pharmacological Basis of Therapeutics | Harrison's Principles of Internal Medicine 22e | Lippincott Illustrated Reviews: Pharmacology | Medical Physiology (Boron & Boulpaep)

Step 1 topper like hy and short including everything

Fibrinolysis — Step 1 Topper Notes ⚡


THE MASTER EQUATION

Plasminogen  ──[tPA / uPA]──►  PLASMIN  ──►  Fibrin  ──►  D-dimer + FDPs
                                    ▲
                          (on clot surface only)

KEY PLAYERS — One Line Each

PlayerWhat It IsOne-liner
PlasminogenInactive zymogenCirculates in blood; activated ON the fibrin clot
tPATissue plasminogen activatorMade by endothelium; main physiologic activator
uPA (urokinase)Urokinase-type PAExtravascular fibrinolysis; inflammatory states
PlasminActive serine proteaseThe actual "clot dissolver"
PAI-1Plasminogen activator inhibitor-1Blocks tPA/uPA → made by endothelium
α₂-antiplasminPlasmin inhibitorDestroys free plasmin; can't reach clot-bound plasmin
TAFIThrombin-activatable fibrinolysis inhibitorRemoves lysines from fibrin → slows lysis

WHY PLASMIN IS CLOT-SPECIFIC (Most Tested Concept)

  • Plasminogen and tPA both have kringle domains → bind lysine residues on fibrin
  • Forms ternary complex: Fibrin + Plasminogen + tPA → plasmin generated locally
  • Plasmin on fibrin surface = kringle domains occupied = α₂-antiplasmin CANNOT bind = protected
  • Partial digestion of fibrin exposes MORE C-terminal lysines → positive feedback → faster lysis
  • Free plasmin (escapes clot) → instantly killed by α₂-antiplasmin
High-dose tPA (pharmacologic) → overwhelms PAI-1 and α₂-antiplasmin → clot specificity LOST → systemic lysis → BLEEDING

PRODUCTS OF FIBRINOLYSIS

ProductSourceSignificance
D-dimerPlasmin on cross-linked fibrin (Factor XIIIa-stabilized)Diagnoses active clot formation + lysis (DVT/PE, DIC)
FDPs (fibrin/fibrinogen degradation products)Plasmin on fibrin OR fibrinogenLess specific; elevated in DIC, liver disease
D-dimer requires cross-linked fibrin → needs Factor XIIIa to have acted first → not elevated from fibrinogen breakdown alone

DRUGS — THE WHOLE TABLE

🔴 Pro-Fibrinolytic (Thrombolytics) — "Clot Busters"

DrugMechanismFibrin-Specific?Key Facts
Alteplase (tPA)Recombinant tPA✅ YesStroke (≤4.5 hrs), STEMI, massive PE
ReteplasetPA variant✅ YesDouble IV bolus; STEMI
Tenecteplase (TNK)Engineered tPA✅ YesSingle weight-based bolus; STEMI
StreptokinaseBacterial → forms plasminogen-activator complex❌ NoAntigenic → allergic rxn; can't re-use (antibodies); systemic lysis
UrokinaseDirectly converts plasminogen → plasmin❌ NoCatheter-directed thrombolysis

🟢 Anti-Fibrinolytic (Hemostatics) — "Clot Protectors"

DrugMechanismUses
Aminocaproic acidLysine analogue → blocks kringle domains → no plasminogen binding to fibrinPost-op bleeding, hemophilia, tonsillectomy
Tranexamic acid (TXA)Same mechanismTrauma, surgery, heavy periods
Both are competitive inhibitors of plasminogen/plasmin binding to fibrin — they occupy the lysine-binding sites

CONTRAINDICATIONS TO THROMBOLYTICS (Absolute)

  • Prior intracranial hemorrhage (ever)
  • Ischemic stroke within 3 months (except: treating acute stroke <4.5 hrs)
  • Suspected aortic dissection
  • Active internal bleeding (not menses)
  • Severe uncontrolled HTN (SBP >180 / DBP >110)
  • Recent significant head/face trauma (<3 months)

DIC — THE PATHOLOGIC EXTREME

Both coagulation AND fibrinolysis go haywire simultaneously
LabValueWhy
PT / aPTTClotting factors consumed
FibrinogenConsumed + degraded by plasmin
PlateletsConsumed in microthrombi
D-dimer↑↑Massive clot lysis
FDPs↑↑Fibrin/fibrinogen degradation
SmearSchistocytesRBCs sheared by fibrin strands
Causes: Sepsis, trauma, obstetric emergencies (abruption, amniotic fluid embolism, retained products), malignancy (esp. AML-M3 / APL)
Treatment: Treat underlying cause — if uncontrolled, often fatal

D-DIMER CLINICAL USE

SituationD-dimer
Suspected DVT/PE (low pre-test probability)If negative → rules OUT (high sensitivity)
DIC↑↑ (with ↓ fibrinogen, ↓ platelets)
Post-surgery / pregnancy / cancerFalse positive (↑ but not diagnostic)
Fibrinogenolysis only (no cross-linked fibrin)Normal D-dimer, elevated FDPs only

RAPID-FIRE HY FACTS

  • tPA made by → endothelial cells
  • tPA cleared rapidly from blood by → PAI-1
  • Fibrin specificity mechanism → kringle domains + lysine residues
  • tPA efficiency on fibrin vs. alone → >300× faster on fibrin surface
  • Factor XIIIa does TWO things: ① cross-links fibrin strands ② cross-links α₂-antiplasmin onto fibrin (prevents early lysis)
  • TAFI activated by → thrombin + thrombomodulin complex
  • Streptokinase → antigenic → cannot re-administer (neutralizing antibodies)
  • Bleeding from thrombolytics → plasmin degrades Factors V and VIII → impairs future thrombin generation
  • Aminocaproic acid = anti-fibrinolytic → lysine analogue (same as TXA)
  • D-dimer = specifically from Factor XIIIa cross-linked fibrin degradation

ONE-LINER SUMMARY

tPA (from endothelium) converts plasminogen → plasmin on fibrin surface (via kringle-lysine binding); plasmin digests cross-linked fibrin → D-dimer; free plasmin is killed by α₂-antiplasmin; tPA is killed by PAI-1; drugs mimicking tPA = thrombolytics; drugs blocking lysine binding = antifibrinolytics.
attachment

Can you make a time table daily to solve questions of complete u world starting from today till june 30

Asking for Preferences
Here's your complete plan:

UWorld Step 1 Complete Timetable

May 19 → June 30 | Sundays Off


The Numbers

StatValue
Total questions3,658
Total days (May 19 – Jun 30)43 days
Sundays off (May 25, Jun 1, 8, 15, 22, 29)6 days
Active study days37 days
Questions/day needed3658 ÷ 37 = ~99 Qs/day
Target: 100 Qs/dayFinishes entire bank with buffer

Daily Schedule (8–9 hrs/day)

TimeActivityDuration
8:00–8:30 AMMorning review — yesterday's marked/incorrect30 min
8:30–10:30 AMBlock 1 — 40 Qs (Timed)2 hrs
10:30–11:30 AMReview Block 1 explanations deeply1 hr
11:30–1:30 PMBlock 2 — 40 Qs (Timed)2 hrs
1:30–2:30 PMLunch break1 hr
2:30–3:30 PMReview Block 2 explanations1 hr
3:30–4:30 PMBlock 3 — 20 Qs (Tutor mode)1 hr
4:30–5:15 PMReview Block 3 + make notes45 min
5:15–6:00 PMRapid-fire revision — FA/Sketchy/Anki on today's topics45 min
80 Qs timed + 20 Qs tutor = 100 Qs/day with full review each day

Subject Allocation by Week

Based on your qbank breakdown (heaviest subjects first):
WeekDatesSubjectsTotal Qs
Week 1May 19–24Pathology (819 Qs) — Part 1~600
Week 2May 26–31Pathology finish (219) + Pharmacology start (331)~550
Week 3Jun 2–7Pharmacology finish (219) + Pathophysiology start (231)~450
Week 4Jun 9–14Pathophysiology finish (257) + Anatomy (308)~565
Week 5Jun 16–21Microbiology (348) + Behavioral Science start (154)~500
Week 6Jun 23–28Behavioral Sci finish (100) + Physiology (268) + Biochemistry (159)~527
Final pushJun 29–30Immunology (132) + Biostatistics (121) + Genetics (107) + Embryology (75) + Histology (29)~464

Week-by-Week Daily Breakdown

WEEK 1 — May 19–24 | Pathology

DayDateFocusQs
MonMay 19Pathology — Cell injury, Inflammation, Neoplasia100
TueMay 20Pathology — Cardiovascular100
WedMay 21Pathology — Pulmonary100
ThuMay 22Pathology — GI + Hepatobiliary100
FriMay 23Pathology — Renal + Endocrine100
SatMay 24Pathology — Heme/Onc + MSK100
SunMay 25OFF

WEEK 2 — May 26–31 | Pathology + Pharmacology

DayDateFocusQs
MonMay 26Pathology — Neuro + Repro (finish)100
TueMay 27Pathology — Remaining + Review weak areas119
WedMay 28Pharmacology — Autonomic + CNS drugs100
ThuMay 29Pharmacology — Cardiovascular drugs100
FriMay 30Pharmacology — Antimicrobials100
SatMay 31Pharmacology — Endocrine + Chemo drugs100
SunJun 1OFF

WEEK 3 — Jun 2–7 | Pharmacology + Pathophysiology

DayDateFocusQs
MonJun 2Pharmacology — Remaining (finish)~150
TueJun 3Pathophysiology — Cardio100
WedJun 4Pathophysiology — Pulm + Renal100
ThuJun 5Pathophysiology — GI + Endocrine100
FriJun 6Pathophysiology — Neuro + Heme100
SatJun 7Pathophysiology — Remaining (finish)~88
SunJun 8OFF

WEEK 4 — Jun 9–14 | Anatomy

DayDateFocusQs
MonJun 9Anatomy — Head & Neck100
TueJun 10Anatomy — Upper limb + Lower limb100
WedJun 11Anatomy — Thorax + Abdomen100
ThuJun 12Anatomy — finish (8 Qs leftover) + Microbiology — Bacteria100
FriJun 13Microbiology — Viruses100
SatJun 14Microbiology — Fungi + Parasites100
SunJun 15OFF

WEEK 5 — Jun 16–21 | Microbiology + Behavioral Science

DayDateFocusQs
MonJun 16Microbiology — Remaining + Behavioral Sci start100
TueJun 17Behavioral Science — Epidemiology + Ethics100
WedJun 18Behavioral Science — finish + Physiology start100
ThuJun 19Physiology — Cardio + Pulm100
FriJun 20Physiology — Renal + GI100
SatJun 21Physiology — Neuro + Endocrine (finish)68
SunJun 22OFF

WEEK 6 — Jun 23–28 | Biochemistry + Small Subjects

DayDateFocusQs
MonJun 23Biochemistry — Metabolism + Molecular bio100
TueJun 24Biochemistry — finish (59) + Immunology start100
WedJun 25Immunology — finish (32 leftover) + Biostatistics100
ThuJun 26Biostatistics — finish (21) + Genetics100
FriJun 27Genetics — finish (7) + Embryology100
SatJun 28Embryology — finish + Histology (29) + Spillover/Review~54
SunJun 29OFF

FINAL 1 DAY — Jun 30

DayDateActivity
MonJun 30Full comprehensive review — All marked questions + weak subjects. Do a mixed 40Q timed block to simulate real test feel.

Rules for Review (Non-Negotiable)

  1. Never skip explanations — read every explanation, even for correct answers
  2. Mark aggressively — if you're not 100% sure, mark it
  3. Wrong answer notebook — one line per wrong answer: "Q topic → Why I was wrong → Correct concept"
  4. Saturday = light day — fewer new Qs, more review of the week's weak spots
  5. Sunday = full off — your brain needs it

Weekly Check-In Targets

End of WeekQs Completed% Done
May 24~60016%
May 31~1,21933%
Jun 7~1,75748%
Jun 14~2,35764%
Jun 21~2,95781%
Jun 28~3,51196%
Jun 303,658100% ✅

Bottom line: 100 Qs/day, 6 days/week, 37 active days = entire UWorld done with 1 full review day left. Stick to the 80 timed + 20 tutor split so you build speed AND understand concepts simultaneously.

Wait today is april 13 2026 make from tomorrow

UWorld Step 1 Complete Timetable

April 14 → June 30, 2026 | Sundays Off


The Numbers

StatValue
Total questions3,658
Total days (Apr 14 – Jun 30)78 days
Sundays off (Apr 19, 26, May 3, 10, 17, 24, 31, Jun 7, 14, 21, 28)11 days
Active study days67 days
Questions/day needed3658 ÷ 67 = ~55 Qs/day
Target: 60 Qs/dayFinishes bank with ~5 days buffer for revision

Great news — you have a very comfortable timeline. 60 Qs/day is very doable in 8–9 hrs, leaving significant time for deep review, notes, and Anki/FA alongside each subject.

Daily Schedule (8–9 hrs/day)

TimeActivityDuration
8:00–8:30 AMMorning review — previous day's marked/incorrect Qs30 min
8:30–10:00 AMBlock 1 — 40 Qs (Timed mode)1.5 hrs
10:00–11:15 AMDeep review of Block 1 explanations + notes1 hr 15 min
11:15–11:30 AMShort break15 min
11:30–12:30 PMBlock 2 — 20 Qs (Tutor mode)1 hr
12:30–1:30 PMLunch break1 hr
1:30–2:30 PMReview Block 2 + update wrong answer log1 hr
2:30–4:30 PMFirst Aid / Sketchy / Pathoma — parallel reading of today's subject2 hrs
4:30–5:30 PMAnki / Flashcard review (new + due cards)1 hr
5:30–6:00 PMPlan tomorrow, review weak points30 min
40 timed + 20 tutor = 60 Qs/day with full deep review + resource reading every day

Subject Allocation Plan

SubjectQsDays Needed @ 60/day
Pathology819~14 days
Pharmacology550~9 days
Pathophysiology488~8 days
Anatomy308~5 days
Microbiology348~6 days
Behavioral Science254~4 days
Physiology268~4 days
Biochemistry159~3 days
Immunology132~2 days
Biostatistics121~2 days
Genetics107~2 days
Embryology75~1 day
Histology29~1 day
TOTAL3,658~61 days → done by ~Jun 18
Leaves Jun 19–30 (12 days) purely for revision of wrong/marked questions

Full Week-by-Week Schedule


WEEK 1 — Apr 14–19 | Pathology: Foundations

DayDateSubject FocusQs
MonApr 14Pathology — Cell injury, Apoptosis, Necrosis60
TueApr 15Pathology — Inflammation (acute + chronic)60
WedApr 16Pathology — Tissue repair, Wound healing60
ThuApr 17Pathology — Neoplasia (basics, carcinogenesis)60
FriApr 18Pathology — Hematologic neoplasms (leukemia/lymphoma)60
SatApr 19Pathology — Vascular pathology60
SunApr 19OFF ☀️

WEEK 2 — Apr 21–26 | Pathology: Organ Systems

DayDateSubject FocusQs
MonApr 21Pathology — Cardiovascular60
TueApr 22Pathology — Pulmonary60
WedApr 23Pathology — GI (esophagus → small bowel)60
ThuApr 24Pathology — GI (colon, liver, pancreas)60
FriApr 25Pathology — Renal60
SatApr 26Pathology — Endocrine60
SunApr 26OFF ☀️

WEEK 3 — Apr 28 – May 3 | Pathology: Finish + Pharmacology Start

DayDateSubject FocusQs
MonApr 28Pathology — MSK + Derm60
TueApr 29Pathology — Neuro + Repro (finish Pathology ✅)60
WedApr 30Pharmacology — Autonomic nervous system60
ThuMay 1Pharmacology — CNS drugs (antidepressants, antipsychotics)60
FriMay 2Pharmacology — CNS drugs (antiepileptics, anesthesia, opioids)60
SatMay 3Pharmacology — Cardiovascular drugs (antihypertensives, antiarrhythmics)60
SunMay 3OFF ☀️

WEEK 4 — May 5–10 | Pharmacology: Finish

DayDateSubject FocusQs
MonMay 5Pharmacology — Cardiovascular (statins, anticoagulants, antiplatelets)60
TueMay 6Pharmacology — Antimicrobials Part 1 (cell wall, protein synthesis)60
WedMay 7Pharmacology — Antimicrobials Part 2 (quinolones, antifungals, antivirals)60
ThuMay 8Pharmacology — Endocrine drugs (insulin, thyroid, steroids)60
FriMay 9Pharmacology — Chemotherapy + Immunosuppressants (finish Pharmacology ✅)60
SatMay 10Pathophysiology — Cardiovascular60
SunMay 10OFF ☀️

WEEK 5 — May 12–17 | Pathophysiology

DayDateSubject FocusQs
MonMay 12Pathophysiology — Pulmonary60
TueMay 13Pathophysiology — Renal (AKI, CKD, acid-base)60
WedMay 14Pathophysiology — GI + Hepatobiliary60
ThuMay 15Pathophysiology — Endocrine60
FriMay 16Pathophysiology — Hematology (anemias, coagulation)60
SatMay 17Pathophysiology — Neuro + Repro (finish Pathophysiology ✅)60
SunMay 17OFF ☀️

WEEK 6 — May 19–24 | Microbiology

DayDateSubject FocusQs
MonMay 19Microbiology — Bacteriology Part 1 (Gram +ve)60
TueMay 20Microbiology — Bacteriology Part 2 (Gram –ve, atypicals)60
WedMay 21Microbiology — Virology (DNA viruses, RNA viruses)60
ThuMay 22Microbiology — Mycology + Parasitology60
FriMay 23Microbiology — Remaining (finish Microbiology ✅)60
SatMay 24Anatomy — Head & Neck60
SunMay 24OFF ☀️

WEEK 7 — May 26–31 | Anatomy + Behavioral Science

DayDateSubject FocusQs
MonMay 26Anatomy — Upper limb + Lower limb60
TueMay 27Anatomy — Thorax + Abdomen60
WedMay 28Anatomy — Neuroanatomy (finish Anatomy ✅)60
ThuMay 29Behavioral Science — Biostatistics/Epidemiology within BS60
FriMay 30Behavioral Science — Ethics, Development, Psychiatry60
SatMay 31Behavioral Science — finish (finish Behavioral Science ✅)60
SunMay 31OFF ☀️

WEEK 8 — Jun 2–7 | Physiology + Biochemistry

DayDateSubject FocusQs
MonJun 2Physiology — Cardiovascular + Pulmonary60
TueJun 3Physiology — Renal + GI60
WedJun 4Physiology — Neuro + Endocrine (finish Physiology ✅)60
ThuJun 5Biochemistry — Metabolism (glycolysis, TCA, FA)60
FriJun 6Biochemistry — Molecular biology + Nutrition (finish Biochemistry ✅)60
SatJun 7Immunology — Innate + Adaptive immunity60
SunJun 7OFF ☀️

WEEK 9 — Jun 9–14 | Small Subjects: Finish All

DayDateSubject FocusQs
MonJun 9Immunology — finish (finish Immunology ✅)72
TueJun 10Biostatistics — Full (finish Biostatistics ✅)60
WedJun 11Genetics — Full (finish Genetics ✅)60
ThuJun 12Embryology + Histology — Full (finish both ✅)60
FriJun 13🎉 QBANK COMPLETE — Mixed weak subject review block60
SatJun 14Revision Day 1 — All Incorrect Qs (252 total) Part 160
SunJun 14OFF ☀️

WEEK 10 — Jun 16–21 | Pure Revision

DayDateActivityQs
MonJun 16Revision — Incorrect Qs Part 260
TueJun 17Revision — All Marked Qs (65 total) + Omitted Part 160
WedJun 18Revision — Omitted Qs Part 2 (259 total)60
ThuJun 19Revision — Omitted Qs finish + Mixed timed block (simulate exam)60
FriJun 20Mixed timed block — Pathology + Pharmacology (highest yield)60
SatJun 21Mixed timed block — Micro + Physio + Biochem60
SunJun 21OFF ☀️

FINAL WEEK — Jun 23–30 | Power Revision

DayDateActivity
MonJun 23Weak subject deep dive (whatever scored lowest)
TueJun 24Mixed 60Q timed block — all subjects random
WedJun 25Behavioral Science + Biostatistics revision (pure memorization)
ThuJun 26Pharmacology rapid review — mechanisms + side effects only
FriJun 27Pathology rapid review — classic findings + buzzwords
SatJun 28Full 40Q timed mock block — exam simulation
SunJun 28OFF ☀️
MonJun 29Final review — only your flagged/wrong answer notebook
TueJun 30Light day — No new Qs. Only read notes. Rest. Sleep early.

Progress Checkpoints

CheckpointDateQs Done% Complete
End Week 1Apr 19~36010%
End Week 2Apr 26~72020%
End Week 4May 10~1,44039%
End Week 6May 24~2,16059%
End Week 8Jun 7~2,88079%
Qbank completeJun 13~3,658100%
Jun 30Jun 30Revision doneReady 🎯

Golden Rules

  1. Never skip explanations — read every one, even when correct
  2. Wrong answer log — one line: Topic → Why wrong → Correct concept
  3. Timed mode always for the 40Q block — builds exam stamina
  4. Read First Aid alongside each subject as you do UWorld
  5. Sundays = full off — no guilt, your brain consolidates on rest days
  6. If you miss a day — don't try to catch up with 120 Qs next day; just resume normally

Can you make a pdf please

Writing File
Your file is ready at:
📄 /home/user/uworld_timetable.html

To save it as a PDF:
  1. Open the file in any browser (Chrome, Edge, Firefox)
  2. Press Ctrl+P (or Cmd+P on Mac)
  3. Set destination to "Save as PDF"
  4. Paper size: A4, Margins: Default
  5. Enable "Background graphics" so the colors print properly
  6. Click Save

The PDF includes everything — color-coded weekly tables, subject breakdown, daily schedule, progress checkpoints, golden rules, and Sunday rest days clearly marked in yellow. Green rows = subject completion milestones, purple rows = revision days.

I cant open

Unfortunately, I can't generate or export actual downloadable PDF/HTML files that you can open on your device — the file only exists on the server side and isn't accessible to you directly.
Here's what you can do to get a PDF:

Option 1 — Copy from chat (easiest)
  1. Scroll up to the full timetable I wrote in the previous message
  2. Select all the text → paste into Microsoft Word or Google Docs
  3. File → Download as PDF

Option 2 — Google Docs (best formatting)
  1. Open docs.google.com
  2. Paste the timetable text
  3. Use Format → Table to recreate the tables
  4. File → Download → PDF

Option 3 — Notion (cleanest)
  1. Open notion.so
  2. Create a new page → paste the content
  3. Click the ... menu → Export → PDF

Option 4 — I generate a cleaner plain-text version I can rewrite the entire timetable in a clean plain format that you can directly paste into Word and it'll look good instantly — just say the word and I'll do it right now.

Which option works best for you?
This is a shared conversation. Sign in to Orris to start your own chat.